Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
AKBA —
AKEBIA THERAPEUTICS INC
CUSIP: 00972D105 · Held by 2 superinvestors · Combined value: $13,873,483
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $8,088,539 | 5,023,937 | ADD | +1,502,211 |
| 2 | Jim Simons | 0.0% | $5,784,944 | 3,593,133 | REDUCE | -359,594 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +1,502,211 | +42.7% |
| Jim Simons | REDUCE | -359,594 | -9.1% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +980,136 | +38.6% |
| Jim Simons | REDUCE | -241,700 | -5.8% |
Who Owns AKBA? Superinvestor Holdings
AKEBIA THERAPEUTICS INC is held by 2 tracked superinvestors, with a combined position value of $14 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.